Aspect Biosystems to Present on Pancreatic Tissue Therapeutic at American Diabetes Association 82nd Scientific Sessions
The poster at ADA 2022 will highlight the development of Aspect’s bioengineered pancreatic tissue therapeutic VANCOUVER, B.C. – Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics… Read More




